Fibrin sealants and high strength medical adhesives will drive the strongest growth over the next decade among all wound closure or "securement" types as surgeons use these products in an increasing proportion of surgeries and as surgeons develop new uses for them, alone or in conjunction with other closure products.
Size and Growth of Surgical Securement Product Segments Worldwide 2010-2019
Source: "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015." Published by MedMarket Diligence, LLC.
This field is expanding rapidly as new devices allow the surgeon to perform closure more quickly and with improved outcomes for patients. A significant premium is possible when new products and devices enable complex securement procedures to be performed under minimally invasive protocols with significant time-savings in the operating room. New technologies and new biomaterials allow improved tissue repair, and it is possible to revalue segments of this market based on significant improvements in clinical practice. This market will triple in value over the next decade.
The total market potential by 2015, driven by procedure volumes, for hemostats, sealants, and glues, addressable by currently available products, more than $2.4 billion for hemostats, $1.7 for sealants, and more than $1.2 billion for skin wound closure using high-strength glues. The introduction of a high-strength, elastic glue without toxicity concerns is expected to further disrupt the traditional wound closure market and lead to even higher sales potential for advanced closure types.
In the field of post-operative adhesion control, newly developed products improve on early prototypes and have substantial clinical efficacy data to allow for a significant premium cost. The market for these products has yet to realize much of its potential and is expected to nearly double in the next five years.